Home › Stocks › ABMD US-listed stock · ABMD
ABIOMED, Inc. (ABMD): trades by Congress and insiders
No trades disclosed in the last 12 months; 14 disclosures on record in all.
Congress trades 012 months
Members trading 012 months
Insider buys / sales 0 / 012 months 14 disclosed buys and sales on record since 6 January 2020. Insider counts are open-market trades only: awards, option exercises and tax withholding are left out.
Latest disclosures
Disclosed Filed by Type Amount Traded
6 Dec 2022 Ro Khanna House · D-CA Buy $1K–$15K
3 Nov 2022
16 Oct 2022 Josh Gottheimer House · D-NJ Sale $1K–$15K
14 Sep 2022
7 Jul 2022 Ro Khanna House · D-CA Sale $1K–$15K
16 Jun 2022
7 Jul 2022 Ro Khanna House · D-CA Sale $1K–$15K
17 Jun 2022
8 Mar 2022 Ro Khanna House · D-CA Buy $1K–$15K
14 Feb 2022
11 Jan 2021 Gilbert Cisneros House · D-CA Buy $1K–$15K
31 Dec 2020
11 Jan 2021 Gilbert Cisneros House · D-CA Buy $1K–$15K
23 Dec 2020
14 Sep 2020 Gilbert Cisneros House · D-CA Buy $1K–$15K
11 Aug 2020
Columns are written from public disclosures: House and Senate periodic transaction reports, SEC Form 4, Japan’s EDINET large-holding reports and Taiwan’s insider registers and market data (TWSE, TPEx, MOPS and the central bank, with history from FinMind). Stock pages add SEC 13F fund holdings and company financials, analysts’ figures from Financial Modeling Prep and Finnhub, and lobbying and federal contract records from the Senate and USAspending.gov. Amounts are disclosed as ranges, so the figures are estimates. Nothing here is investment advice.
Home · Features · Columns · Members of Congress · Stocks · Sitemap · RSS feed of the columns · Privacy and security
Follow us on X Bluesky LinkedIn